Public Perspectives on COVID-19 Vaccine Prioritization

被引:41
|
作者
Persad, Govind [1 ]
Emanuel, Ezekiel J. [2 ]
Sangenito, Samantha [3 ,4 ]
Glickman, Aaron [5 ]
Phillips, Steven [6 ]
Largent, Emily A. [5 ]
机构
[1] Univ Denver, Sturm Coll Law, Denver, CO USA
[2] Univ Penn, Perelman Sch Med, Dept Med Eth & Hlth Policy, 423 Guardian Dr, Philadelphia, PA 19104 USA
[3] Univ Penn, Fels Inst Govt, Philadelphia, PA 19104 USA
[4] Univ Penn, Penn Program Opin Res & Elect Studies, Philadelphia, PA 19104 USA
[5] Univ Penn, Perelman Sch Med, Dept Med Eth & Hlth Policy, Leonard Davis Inst Hlth Econ, Philadelphia, PA 19104 USA
[6] COVID Collaborat, Washington, DC USA
关键词
ALLOCATING INITIAL SUPPLIES; ADVISORY-COMMITTEE; UNITED-STATES; INTERIM RECOMMENDATION;
D O I
10.1001/jamanetworkopen.2021.7943
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
IMPORTANCE As COVID-19 vaccine distribution continues, policy makers are struggling to decide which groups should be prioritized for vaccination. OBJECTIVE To assess US adults' preferences regarding COVID-19 vaccine prioritization. DESIGN, SETTING, AND PARTICIPANTS This survey study involved 2 independent, online surveys of US adults aged 18 years and older, 1 conducted by Gallup from September 14 to 27, 2020, and the other conducted by the COVID Collaborative from September 19 to 25, 2020. Samples were weighted to reflect sociodemographic characteristics of the US population. EXPOSURES Respondents were asked to prioritize groups for COVID-19 vaccine and to rank their prioritization considerations. MAIN OUTCOMES AND MEASURES The study assessed prioritization preferences and agreement with the National Academies of Science, Engineering, and Medicine's Preliminary Framework for Equitable Allocation of COVID-19 Vaccine. RESULTS A total of 4735 individuals participated, 2730 (1474 men [54.1%]; mean [SD] age, 59.2 [14.5] years) in the Gallup survey and 2005 (944 men [47.1%]; 203 participants [21.5%] aged 55-59 years) in the COVID Collaborative survey. In both the Gallup COVID-19 Panel and COVID Collaborative surveys, respondents listed health care workers (Gallup, 93.6% [95% CI, 91.2%-95.3%]; COVID Collaborative, 80.0% [95% CI, 78.0%-81.9%]) and adults of any age with serious comorbid conditions (Gallup, 78.6% [95% CI, 75.2%-81.7%]; COVID Collaborative, 72.9% [95% CI, 70.7%-74.9%]) among their 4 highest priority groups. Respondents of all political affiliations agreed with prioritizing Black, Hispanic, Native American, and other communities that have been disproportionately affected by COVID-19 (Gallup, 74.2% [95% CI, 70.6%-77.5%]; COVID Collaborative, 84.9% [95% CI, 83.1%-86.5%]), and COVID Collaborative respondents were willing to be preceded in line by teachers and childcare workers (92.5%; 95% CI, 91.2%-93.7%) and grocery workers (85.9%; 95% CI, 84.2%-87.5%). Older respondents in both surveys were significantly less likely than younger respondents to prioritize healthy adults aged 65 years and older among their 4 highest priority groups (Gallup, 23.7% vs 39.1% [chi(2) = 2160.8; P < .001]; COVID Collaborative, 23.3% vs 28.8% [chi(2) = 5.0198; P = .03]). COVID Collaborative respondents believed the 4 most important considerations for prioritization were preventing COVID-19 spread (78.4% [95% CI, 76.3%-80.3%]), preventing the most deaths (72.1% [95% CI, 69.9%-74.2%]), preventing long-term complications (68.9% [66.6%-71.9%]), and protecting frontline workers (63.8% [95% CI, 61.5%-66.1%]). CONCLUSIONS AND RELEVANCE US adults broadly agreed with the National Academies of Science, Engineering, and Medicine's prioritization framework. Respondents endorsed prioritizing racial/ethnic communities that are disproportionately affected by COVID-19, and older respondents were significantly less likely than younger respondents to endorse prioritizing healthy people older than 65 years. This provides reason for caution about COVID-19 vaccine distribution plans that prioritize healthy adults older than a cutoff age without including those younger than that age with preexisting conditions, that aim solely to prevent the most deaths, or that give no priority to frontline workers or disproportionately affected communities.
引用
收藏
页数:12
相关论文
共 50 条
  • [1] COVID-19 vaccine mandates: what are the current European public perspectives?
    Vergallo, G. Montanari
    Del Rio, A.
    Negro, F.
    Zaami, S.
    [J]. EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2022, 26 (02) : 643 - 652
  • [2] Ethical perspective for the COVID-19 vaccine prioritization in Chile
    Garcia, Christian
    Luco, Lorna
    Ines Gomez, Maria
    Martinez, Claudio
    [J]. REVISTA MEDICA DE CHILE, 2021, 149 (12) : 1795 - 1800
  • [3] Queue questions: Ethics of COVID-19 vaccine prioritization
    Giubilini, Alberto
    Savulescu, Julian
    Wilkinson, Dominic
    [J]. BIOETHICS, 2021, 35 (04) : 348 - 355
  • [4] COVID-19 Vaccine Prioritization Must be Driven by Science
    Yale, Steven H.
    Tekiner, Halil
    Mazza, Joseph J.
    Yale, Eileen S.
    [J]. ERCIYES MEDICAL JOURNAL, 2021, 43 (03) : 305 - 306
  • [5] An alternative vaccine prioritization approach in response to COVID-19 pandemic
    Sahinyazan, Feyza G.
    Araz, Ozgur M.
    [J]. JOURNAL OF HUMANITARIAN LOGISTICS AND SUPPLY CHAIN MANAGEMENT, 2022, 12 (04) : 532 - 553
  • [6] Public opinion on COVID-19 vaccine prioritization in Bangladesh: Who gets the vaccine and whom do you leave out?
    Biswas, Raaj Kishore
    Afiaz, Awan
    Huq, Samin
    Farzana, Maysha
    Kabir, Enamul
    [J]. VACCINE, 2023, 41 (34) : 5018 - 5028
  • [7] Perspectives on RNA Vaccine Candidates for COVID-19
    Borah, Pobitra
    Deb, Pran Kishore
    Al-Shar'i, Nizar A.
    Dahabiyeh, Lina A.
    Venugopala, Katharigatta N.
    Singh, Vinayak
    Shinu, Pottathil
    Hussain, Snawar
    Deka, Satyendra
    Chandrasekaran, Balakumar
    Jaradat, Da'san M. M.
    [J]. FRONTIERS IN MOLECULAR BIOSCIENCES, 2021, 8
  • [8] The ethics of COVID-19 vaccine mandates for healthcare workers: Public health and clinical perspectives
    Gur-Arie, Rachel
    Hutler, Brian
    Bernstein, Justin
    [J]. BIOETHICS, 2023, 37 (04) : 331 - 342
  • [9] Risk factor targeting for vaccine prioritization during the COVID-19 pandemic
    Lloyd A. C. Chapman
    Poojan Shukla
    Isabel Rodríguez-Barraquer
    Priya B. Shete
    Tomás M. León
    Kirsten Bibbins-Domingo
    George W. Rutherford
    Robert Schechter
    Nathan C. Lo
    [J]. Scientific Reports, 12
  • [10] Geo-prioritization framework for COVID-19 vaccine allocation in India
    Mahajan, Akshay
    Kaur, Jasmine
    Sidana, Chirag
    Shivam, Shashwat
    Singh, Harpreet
    [J]. VACCINE, 2021, 39 (37) : 5254 - 5256